performed at the central laboratory of our university. All athletes were
allowed to maintain their daily exercises program even on the day before
blood sample collection. The athletes had very similar exercise training
programs, corresponding to two long-distance running sessions every day, 15
km in the morning and 10 km in the afternoon, and intensive training
(100-1,000 meter shots, repeated many times)twice a week, on Tuesday and
Thursday mornings. All blood samples were collected on Thursdays, before
exercise.
Measurements of EPCs and MPs were performed as previously reported, using
fresh blood samples in EDTA containing tubes.12 (link)-15 (link)For determination of EPCs, a minimum of 500,000 events was acquired by
flow-cytometry (FACSCalibur, BD Biosciences, USA). Fluorescently labeled
mouse anti-human antibodies were used for EPCs (CD34 FITC, BD Biosciences,
USA; CD133 APC, Miltenyi Biotec, USA; KDR PE, R&D Systems, USA), PMPs
(CD42 FITC and CD31 PE, BD Biosciences, USA) and EMPs (CD51 FITC, BD
Biosciences). Disposable containers (BD Biosciences) were used to quantify
the number of microparticles per microliter of
platelet-poor plasma (PPP).